Bausch Health Companies (BHC) EBT Margin (2009 - 2026)
Bausch Health Companies (BHC) posted EBT Margin of 12.2% for Q2 2026, up 122.75% sequentially from 53.65% in Q1 2026, and up 667.0% YoY from 1.59% in Q2 2025.
Bausch Health Companies (BHC) EBT Margin (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported EBT Margin for 18 years, with the latest figure at 12.2% in Q2 2026.
- Quarterly EBT Margin rose 667.0% year-over-year to 12.2% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 6.74% (down 960.0% YoY) and the FY2025 annual result came in at 3.57%, up 184.0% from the prior year.
- EBT Margin advanced to 12.2% in Q2 2026 per BHC's latest filing, from 53.65% in the prior quarter.
- Over five years, EBT Margin peaked at 21.46% in Q3 2022 and troughed at 53.65% in Q1 2026.
- A 5-year average of 2.53% and a median of 0.56% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2022 and 2026: EBT Margin surged 2535 bps in 2022, then slumped 5156 bps in 2026.
- Over 5 years, EBT Margin stood at 16.28% in 2022, then soared by 98 bps to 0.29% in 2023, then jumped by 2910 bps to 8.17% in 2024, then sank by 75 bps to 2.0% in 2025, then soared by 509 bps to 12.2% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 12.2%, 53.65%, and 2.0% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 734.50 Mn | 2.10 Bn | 12.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.20% |
| Mar 31, 2026 | -53.65% |
| Dec 31, 2025 | 2.00% |
| Sep 30, 2025 | 8.13% |
| Jun 30, 2025 | 5.53% |
| Mar 31, 2025 | -2.08% |
| Dec 31, 2024 | 8.17% |
| Sep 30, 2024 | -0.84% |
| Jun 30, 2024 | 2.00% |
| Mar 31, 2024 | -3.20% |
| Dec 31, 2023 | -0.29% |
| Sep 30, 2023 | -14.57% |
| Jun 30, 2023 | 3.65% |
| Mar 31, 2023 | -7.00% |
| Dec 31, 2022 | -16.28% |
| Sep 30, 2022 | 21.46% |
| Jun 30, 2022 | -6.56% |
| Mar 31, 2022 | -4.28% |
| Dec 31, 2021 | 0.29% |
| Sep 30, 2021 | 10.23% |